China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents

The COVID-19 pandemic continues to spread all over the world. In the process of emergency use authorization, the Center for Medical Device Evaluation of the China National Medical Products Administration issued ‘Key Points of Technical Review for the Registration of SARS-CoV-2 Antigen/Antibody Detec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yunfeng, Gao, Yu, He, Jingyun, Xu, Chao, Liu, Rongzhi, Zheng, Shengwei, Fang, Li, Han, Congyin, Li, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Newlands Press Ltd 2022
Materias:
Regulatory
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860178/
https://www.ncbi.nlm.nih.gov/pubmed/35188408
http://dx.doi.org/10.4155/bio-2021-0176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860178/
https://www.ncbi.nlm.nih.gov/pubmed/35188408
http://dx.doi.org/10.4155/bio-2021-0176

Ejemplares similares